We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CT Cardiac Function Analysis and Cardiac Calcium Scoring Applications Designed for Visualization System

By HospiMedica International staff writers
Posted on 30 Apr 2009
New analysis imaging applications enhance the productivity and diagnostic capability of physicians when evaluating patients' heart health. More...
Both the cardiac function analysis and calcium scoring applications can be accessed throughout the enterprise on a thin-client system to provide physicians with improved efficiency and real-time collaboration when evaluating results from a computed tomography (CT) cardiac scan.

Ziosoft, Inc. (Redwood, CA, USA), a developer of advanced visualization and analysis software for medical imaging, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market two additional applications for use with the Ziostation thin-client system.

The calcium scoring application is used by physicians to help determine whether a patient may be at increased risk for coronary artery disease. Ziosoft's calcium scoring application features valuable tools for the clinician such as concurrent reading of the calcium analysis adjacent to the original data set, which allows for efficient and precise analysis of data.

The cardiac function application enables physicians to conduct a cardiac functional assessment and includes Ziosoft's unique tools such as automatic left ventricle segmentation, peak-filling rate (PFR), and peak-ejection rate (PER) in addition to the standard functional assessment calculations. The cardiac function application also includes the capability to automatically generate "bulls-eye" maps and a time volume graph to aid in the physician's evaluation.

According to the U.S. National Center for Health Statistics (NCHS; Atlanta, GA, USA) every year since 1900, except 1918, cardiovascular disease accounted for more deaths than any other single cause or group of causes of death in the United States. These new applications from Ziosoft will contribute to more efficient interpretation and improved communication of test results, leading to enhanced quality of care for patients.

"We are proud of our long history of developing software applications which aid physicians in evaluating diseases" said Kazuhiko Matsumoto, Ziosoft's chief executive officer. "These latest applications will be added to Ziosoft's suite of applications for a robust cardiac tool set for the market."

Ziosoft is a developer of networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Ziosoft is the leading independent advanced visualization company in Japan with over 1,800 installed systems. Ziosoft is focused on providing intelligent and intuitive clinical tools across the enterprise.

Related Links:

Ziosoft



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Syringe Pump
SP50 Series
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.